Two more class I recall-related announcements for Medtronic PLC's Heartware Ventricular Assist Device system were posted by US FDA May 4, adding to a string of formal "corrections and removals" linked to the end-stage heart failure device in recent years.
An action initiated in March by Medtronic to replace the HVAD systems' existing driveline splice kit with a new kit due to a design problem that would prevent the repaired...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?